Title: About Results of Successive Application Two «Strategies» of Antiviral Therapy of Chronic Hepatitis B Patients
Abstract: The authors presented main results of their clinical observation for 128 chronic hepatitis B (CHB), which underwent antiviral therapy with pegilated interferon for 6 months. 44,5% of these patients had sustained virological response (SVR).
 Then 55,5% patients who after therapy had no SVR were additionally treated with one of nucleosides analog for 18 month. Finally 6 month later after end of second therapy SVR was registered at more than 90% of CHB patients.